Localization of prostate cancer metastasis-suppressor activity on human chromosome 17

Prostate

Volumn 33, Issue 4, 1997, Pages 271-280

  Chekmareva, Marina A ^a   Hollowell, Courtney M P ^a   Smith, Robert C ^a   Davis, Elizabeth M ^a   LeBeau, Michelle M ^a,b   Rinker Schaeffer, Carrie W ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Human chromosome 17; Metastasis suppressor genes; Prostate cancer

Indexed keywords

DNA;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 17; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC MARKER; HUMAN; HUMAN CELL; MALE; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; TUMOR SUPPRESSOR GENE;

ANIMALS; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; DNA PRIMERS; DNA, NEOPLASM; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RATS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0030867030     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19971201)33:4<271::AID-PROS8>3.0.CO;2-K     Document Type: Article

References (27)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics 1996. CA 1996;46:5-27.
2. Scardino PT, Weaver R, Hudson MA: Early detection of prostate cancer. Hum Pathol 1992;23:211-222.
3. Rinker-Schaeffer CW, Partin A, Isaacs W, Coffey DS, Isaacs JT: Molecular and cellular changes associated with the acquisition of metastatic ability by prostate cancer cells. Prostate 1994;25: 249-265.
4. Ichikawa T, Ichikawa Y, Dong J, Hawkins AL, Griffin CA, Isaacs WB, Oshimura M, Barrett JC, Isaacs JT: Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res 1992;52:3486-3490.
5. Ichikawa T, Nihei N, Suzuki H, Oshimura M, Emi M, Nakamura Y, Hayata I, Isaacs JT, Shimazaki J: Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8. Cancer Res 1994;54:2299-2302.
6. Nihei NIT, Kawana Y, Kuramochi H, Kugo H, Oshimura M, Kiliary AM, Rinker-Schaeffer CW, Barrett JC, Isaacs JT, Shimazaki J: Localization of metastasis-suppressor genes for rat prostatic cancer to the long arm of human chromosome 10. Genes Chromosomes Cancer 1995;14:112-119.
7. Rinker-Schaeffer CW, Hawkins AL, Ru N, Dong J, Stoica G, Griffin CA, Ichikawa T, Barrett JC, Isaacs JT: Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res 1994;54:6249-6256.
8. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995;268:884-886.
9. Murakami YS, Brothman AT, Leach RJ, White RL: Suppression of malignant phenotype in a human prostate cancer cell line by fragments of normal chromosomal region 17q. Cancer Res 1995; 55:3389-3394.
10. Gao X, Zacharek A, Salkowski A, Grignon DJ, Sakr W, Porter AT, Honn KV: Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 1995;55:1002-1005.
11. Rowley JD, Diaz MO, Espinosa RD, Patel YD, van Melle E, Ziemin S, Taillon-Miller P, Lichter P, Evans GA, Kersey JH, Ward DC, Domer PH, Le Beau MM: Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: Identification of 11q23 translocation breakpoints with a yeast artificial chromosome. Proc Natl Acad Sci USA 1990;87:9358-9362.
12. Chapter 2, "Preparation and Analysis of DNA. Current Protocols in Molecular Biology on CD ROM." New York: Wiley, 1996.
13. Hudson TJ, Stein LD, Gerety SS, Ma J, Castle AB, Silva J, Slonim DK, Baptista R, Kruglyak L, Xu SH, Hu X, Colbert AME, Rosenberg C, Reeve-Daly MP, Rozen S, Hui L, Wu X, Vestergaard C, Wilson KM, Bae JS, Maitra S, Ganlatsas S, Evans CA, DeAngells MM, Ingalls KA, Nahf RW, Horton LT, Anderson MO, Collymore AJ, Ye W, Kouyoumjian V, Zemsteva IS, Tam J, Devine R, Courtney DF, Renaud MT, Nguyen H, O'Connor TJ, Orlin JB, Birren BW, Goodman N, Weissenbach J, Hawkins TL, Foote S, Page DC, Lander ES: An STS-based map of the human genome. Science 1996;270:1945-1954.
14. Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB: p53 activates expression of Hic-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1995;1:570-577.
15. Brothman AR, Peehl DM, Patel AM, McNeal JE: Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 1990;50:3795-3803.
16. Brothman A, Steel MR, Williams BJ, Jones E, Odelberg S, Albertsen HM, Jorde LB, Thor LR, Stephenson RA: Loss of chromosome 17 loci in prostate cancer detected by PCR quantification of allelic markers. Genes Chromosomes Cancer 1995;13: 278-284.
17. Ittmann MM: Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma. Prostate 1996;28:275-281.
18. Macoska JA, Powell IJ, Sakr W, Lane MA: Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate. J Urol 1992;147:1142-1146.
19. Gao X, Zacharek A, Grignon DJ, Sakr W, Powell IJ, Porter AT, Honn KV: Localization of potential tumor suppressor loci to a <2 Mb region on chromosome 17q in human prostate cancer. Oncogene 1995;11:1241-1247.
20. Williams BJ, Jones E, Zhu XL, Steele MR, Stephenson RA, Rohr LR, Brothman AR: Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer. J Urol 1996;155:720-725.
21. von Deimling A, Krone W, Menon AG: Neurofibromatosis type 1: Pathology, clinical features and molecular genetics. Brain Pathol 1995;5:153-162.
22. Fink TM, Jenne DE, Lichter P: The human vitronectin (complement S-protein) gene maps to the centromeric region of 17q. Hum Genet 1992;88:669-672.
23. Phillips N, Ziegler M, Saha B, Xynos F: Allelic loss on chromosome 17 in human ovarian cancer. Int J Cancer 1993;54:85-91.
24. Wertheim I, Tangir J, Muto MG, Welch WR, Berkowitz RS, Chen WY, Mok SC: Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Oncogene 1996;12:2147-2153.
25. Adamson R, Jones AS, Field JK: Loss of heterozygosity studies on chromosome 17 in head and neck cancer using microsatellite markers. Oncogene 1994;9;2077-2082.
26. Swift A, Risk JM, Kingsnorth AN, Wright TA, Myskow M, Field JK: Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma. Br J Cancer 1995;71: 995-998.
27. Guzzetta V, Franco B, Trask BJ, Zhang H, Saucedo-Cardenas O, Montes de Oca-Luna R, Greenberg F, Chinault AC, Lupski JR, Patel PI: Somatic cell hybrids, sequence-tagged sites, simple repeat polymorphism, and yeast artificial chromosomes for for physical and genetic mapping of proximal 17p. Genomics 1992;13:551-559.